Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease

Ismail Simsek1, Cem Koz, Nurcan Basar

  • 1Division of Rheumatology, Gulhane School of Medicine, Ankara, Turkey. isimsek1@yahoo.com

Clinical Rheumatology
|July 21, 2010
PubMed

Insights

Familial Mediterranean fever (MEFV) gene mutations were investigated for their role in rheumatic heart disease (RHD) susceptibility. This study found no association between MEFV mutations and RHD predisposition in Turkish patients.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Rheumatology

Background:

  • Rheumatic heart disease (RHD) poses a significant health risk, with genetic factors potentially influencing susceptibility.
  • Familial Mediterranean fever (FMF) is characterized by MEFV gene mutations and heightened inflammatory responses, suggesting a possible link to RHD development.

Purpose of the Study:

  • To investigate the association between MEFV gene mutations and the predisposition to developing RHD in a Turkish population.
  • To determine if specific MEFV mutations confer increased susceptibility to RHD.

Main Methods:

  • A case-control study involving 100 RHD patients and 100 healthy controls from Turkey.
  • Echocardiography was used to diagnose RHD, with mitral stenosis as a key criterion.
  • Sequence analysis was performed on exons 2 and 10 of the MEFV gene to identify mutations.

Main Results:

  • MEFV mutations were detected in 22% of RHD patients and 24% of healthy controls.
  • Allele frequencies for MEFV mutations did not significantly differ between the RHD patient group and the control group (p=0.54).
  • No statistically significant association was found between MEFV mutations and RHD susceptibility.

Conclusions:

  • MEFV gene mutations are not associated with an increased predisposition to developing rheumatic heart disease in adult Turkish patients.
  • The findings suggest that genetic factors related to familial Mediterranean fever do not play a significant role in RHD susceptibility in this population.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...